ConductScience.org, home

Trial · NCT00313313

Results by group30

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Change From Baseline in Hemoglobin A1c (A1C) at Week 24Saxagliptin 2.5 mg + Glyburide 7.5 mgBaseline Mean8.36Standard Error 0.057percent
Change From Baseline in Hemoglobin A1c (A1C) at Week 24Saxagliptin 5 mg + Glyburide 7.5 mgBaseline Mean8.48Standard Error 0.056percent
Change From Baseline in Hemoglobin A1c (A1C) at Week 24Placebo + Glyburide 7.5 mgBaseline Mean8.44Standard Error 0.055percent
Change From Baseline in Hemoglobin A1c (A1C) at Week 24Saxagliptin 2.5 mg + Glyburide 7.5 mgWeek 24 Mean7.83Standard Error 0.074percent
Change From Baseline in Hemoglobin A1c (A1C) at Week 24Saxagliptin 5 mg + Glyburide 7.5 mgWeek 24 Mean7.83Standard Error 0.074percent
Change From Baseline in Hemoglobin A1c (A1C) at Week 24Placebo + Glyburide 7.5 mgWeek 24 Mean8.52Standard Error 0.077percent
Change From Baseline in Hemoglobin A1c (A1C) at Week 24Saxagliptin 2.5 mg + Glyburide 7.5 mgAdjusted Mean Change from Baseline-0.54Standard Error 0.059percent
Change From Baseline in Hemoglobin A1c (A1C) at Week 24Saxagliptin 5 mg + Glyburide 7.5 mgAdjusted Mean Change from Baseline-0.64Standard Error 0.059percent
Change From Baseline in Hemoglobin A1c (A1C) at Week 24Placebo + Glyburide 7.5 mgAdjusted Mean Change from Baseline0.08Standard Error 0.057percent
Change From Baseline in Fasting Plasma Glucose (FPG) at Week 24Saxagliptin 2.5 mg + Glyburide 7.5 mgBaseline Mean170.1Standard Error 2.67mg/dL
Change From Baseline in Fasting Plasma Glucose (FPG) at Week 24Saxagliptin 5 mg + Glyburide 7.5 mgBaseline Mean175.0Standard Error 2.79mg/dL
Change From Baseline in Fasting Plasma Glucose (FPG) at Week 24Placebo + Glyburide 7.5 mgBaseline Mean174.4Standard Error 2.64mg/dL
Change From Baseline in Fasting Plasma Glucose (FPG) at Week 24Saxagliptin 2.5 mg + Glyburide 7.5 mgWeek 24 Mean164.4Standard Error 2.76mg/dL
Change From Baseline in Fasting Plasma Glucose (FPG) at Week 24Saxagliptin 5 mg + Glyburide 7.5 mgWeek 24 Mean164.6Standard Error 2.76mg/dL
Change From Baseline in Fasting Plasma Glucose (FPG) at Week 24Placebo + Glyburide 7.5 mgWeek 24 Mean174.6Standard Error 2.93mg/dL
Change From Baseline in Fasting Plasma Glucose (FPG) at Week 24Saxagliptin 2.5 mg + Glyburide 7.5 mgAdjusted Mean Change from Baseline-7.1Standard Error 2.42mg/dL
Change From Baseline in Fasting Plasma Glucose (FPG) at Week 24Saxagliptin 5 mg + Glyburide 7.5 mgAdjusted Mean Change from Baseline-9.7Standard Error 2.39mg/dL
Change From Baseline in Fasting Plasma Glucose (FPG) at Week 24Placebo + Glyburide 7.5 mgAdjusted Mean Change from Baseline0.7Standard Error 2.33mg/dL
Percentage of Participants Achieving A1C < 7% at Week 24Saxagliptin 2.5 mg + Glyburide 7.5 mg22.4Percentage of participants
Percentage of Participants Achieving A1C < 7% at Week 24Saxagliptin 5 mg + Glyburide 7.5 mg22.8Percentage of participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00313313/results